Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Infantile myofibromatosis is a rare and nonmalignant pediatric tumor of myofibroblastic origin that may occur in solitary or multifocal forms. Soft tissue of the head and neck, trunk, and extremities, skeleton, and viscera are usually involved. Intracranial involvement is reported to be extremely rare, and its clinical picture has been poorly characterized. We present two cases of giant infantile myofibromatosis of the skull base with intracranial involvement. The first case with prenatal diagnosis involved extensively the extradural space of the occipital region and was previously treated by chemotherapy for a previous diagnosis of hemangioperycitoma. Tumor was removed at the age of 5 months and no recurrence was observed during the 3-year follow-up. The second case in a 2-year-old baby involved the anterior cranial base, the nasal cavity, the right orbit, and presented massive involvement of the anterior cranial fossa. Surgery allowed complete removal and a recurrence-free period of 7 years after surgery. Treatment options for these unusual cases are presented and details of histological diagnosis are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00381-021-05271-zDOI Listing

Publication Analysis

Top Keywords

infantile myofibromatosis
12
myofibromatosis skull
8
skull base
8
intracranial involvement
8
anterior cranial
8
giant intracranial
4
intracranial infantile
4
base report
4
report cases
4
cases infantile
4

Similar Publications

Background: Infantile myofibromatosis is a rare benign mesenchymal disorder characterized by the proliferation of myofibroblasts, representing the most common fibrous tumor of infancy and early childhood. Solitary infantile myofibromatosis is the most common variant, typically presenting as a firm, painless dermal or subcutaneous mass. This case is notable for the early prenatal detection of multiple subcutaneous lesions, initially presumed to be lymphangiomas, but later confirmed as infantile myofibromatosis postnatally.

View Article and Find Full Text PDF

PDGFRB-related Penttinen syndrome is characterized by progressive progeroid features, acroosteolysis, and development of aneurysms, structural anomalies of the posterior fossa, variable myofibromatosis, and overgrowth. PDGFRB-related disorders, including Penttinen syndrome, Kosaki syndrome, and infantile myofibromatosis, have been successfully treated using imatinib. Here, we report a child diagnosed in infancy who initiated imatinib monotherapy at 8 months of age and has continued treatment for 4 years.

View Article and Find Full Text PDF

This report describes the case of a 25-year-old female patient with multicentric infantile myofibromatosis since early infancy, superficial capillary malformations and congenital hypoplasia of the third and fourth finger of her right hand. All known lesions were located in the upper extremities, the chest and the upper back. A pathogenic, gain-of-function platelet-derived growth factor receptor-beta (PDGFRB) variant (p.

View Article and Find Full Text PDF

Background: Infantile myofibromatosis, a rare soft tissue neoplasm that may present at birth or in early infancy, is the most common fibrous tumor of infancy and early childhood. Diagnosis could be challenging due to different clinical presentation. Very few cases are detected prenatally and visceral involvement is extremely rare.

View Article and Find Full Text PDF

Infantile myofibromatosis is a well-recognized soft tissue tumor that is usually seen in infants and younger populations. These benign lesions mostly arise in the skin and soft tissues of the head and neck but may also involve visceral organs such as the lung, liver, and gastrointestinal tract. After a clinical diagnosis is made, a histological and immunological workup is performed to identify characteristic features like spindle-shaped cells and positive markers such as alpha-smooth muscle actin and vimentin.

View Article and Find Full Text PDF